All of the women who later died of BC had LGR5-positive (LGR5int/high(1–3)) DCIS tumors, while none of the women with LGR5low(0) experienced BC-related death, accounting for 32% of all DCIS patients (Fig. 3b-c). This evidence concerns the gene LGR5 and breast cancer.